About Us

Our Leadership

Ge Li, Ph.D.
Chairman and CEO
Scientist and entrepreneur leading WuXi since its founding in 2000. Ph.D. in Organic Chemistry from Columbia University. Awards and honors include "2018 SAPA Distinguished Achievement Award", "2018 The 40 Most Influential People in Pharmaceutical Industry in Commemoration of the 40th Anniversary of Reform and Opening-up", "2016 CBA Brilliant Achievement Award", "2015 SCRIP Executive of the Year Award", "2015 The 25 Most Influential People in Biopharma", "2009 The 60 Most Influential People during 60 Years Pharmaceutical Development in China", "2008 Forbes 25 Notable Chinese-Americans", and "2007 Ernst & Young Entrepreneur of the Year China".
Edward Hu
Co-CEO
Co-CEO at WuXi AppTec. With experience in operational excellence, financial management and global business expansion, Mr. Hu has demonstrated his extraordinary leadership to help the business expand further. Prior to WuXi, Mr. Hu served as Senior Vice President and Chief Operating Officer at Tanox. His earlier career spanned managerial and financial positions at Biogen and Merck respectively. Mr. Hu has an MBA and Master's degree in Chemistry from Carnegie Mellon University.
Steve Yang, Ph.D.
Executive Vice President, Chief Business Officer
Formerly Vice President and Head of Asia and Emerging Markets iMed at AstraZeneca, Vice President, Head of R&D Asia at Pfizer. Ph.D. in Pharmaceutical Chemistry from University of California, San Francisco.
Xiaozhong Liu
Executive Vice President
One of our founders, entrepreneur. B.S. from Peking University and EMBA from China Europe International Business School.
Shuhui Chen, Ph.D.
Chief Scientific Officer
Over 27 years' experience in medicinal chemistry, formerly Research Advisor at Eli Lilly, Vion Pharmaceuticals, and Bristol-Myers Squibb. Joined WuXi AppTec in 2004 as Chief Scientific Officer. Ph.D. in Organic Chemistry from Yale University.
Zhaohui Zhang
Senior Vice President of Operations
One of our founders, entrepreneur, formerly Vice President of Domestic Marketing of WuXi AppTec. EMBA from China Europe International Business School.
Ning Zhao, Ph.D.
Senior Vice President of Operations, Global Head of Human Resources
One of our co-founders, formerly Vice President of Analytical Services and Lead Advisor of Analytical Services Operations of WuXi AppTec, previously held various positions at Bristol-Myers Squibb, Pharmacopeia, and Wyeth. Ph.D. in Organic Chemistry from Columbia University.
Ellis Chu
Senior Vice President, CFO
Formerly Managing Director and senior M&A banker at Citigroup and Merrill Lynch, Mr. Chu led the execution on many of the most strategic and transformative cross-border deals. B.S. in Electrical Engineering from Northwestern University and MBA from Columbia Business School.
Peter Tong
Chief Operating Officer
Almost 20 years of experiences and expertise in business, operations and HR management in Huawei. Held progressive positions as Assistant President of Huawei University, Consumer Business Group (CBG) South Pacific Region President, HRVP of CBG, VP of Huawei Group HR department etc. Master and bachelor degrees in legal major from Wuhan University.
Jerry Chen, Ph.D.
Senior Vice President, CDO
Dr. Chen has profound experience in leading strategic designs and practical applications in healthcare big data and Artificial Intelligence. He founded Tencent Medical Big Data Lab, and Alibaba Health's Big Data and AI team. Formerly a tech lead of the Cards team at Twitter in San Francisco. Ph.D. in Computer Science and Engineering from University of Michigan.
Richard Connell, Ph.D.
Senior Vice President, US Chief Operating Officer
Over 27 years of experience in the biotech and drug discovery sector, most recently as Vice President of External Research Solutions at Pfizer. Managed a global network of Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs), Biotech, technology and academic partnerships. Held multiple management positions in the US, UK, Germany and China while at Pfizer and Bayer. Ph.D. in Organic Chemistry from University of Notre Dame.
Jingchao Dong, Ph.D.
Senior Vice President, Head of CSU
One of the founding scientists of the company. Formerly Vice President of International Discovery Service Unit, responsible for the management of Shanghai, Wuhan and Tianjin site. Ph.D. in medicinal chemistry from Peking University.
Fred Hausheer, MD, FACP
Senior Vice President, CMO
Rich experience in global preclinical and Phase I-III oncology drug development, translational science and medicine in commercial and academic settings. Formerly CEO and CMO of several Biopharma companies, the Founder and Chairman of BioNumerik Pharmaceuticals, served as a business advisory board member to JP Morgan Chase, the Whittaker Institute at Johns Hopkins, and the National Cancer Institute. MD from the University of Missouri, School of Medicine, and Medical Oncology fellowship at Johns Hopkins.
Felix Hsu
Senior Vice President, Head of the Advanced Therapy Unit
Over 14 years' experience at Medtronic for MDT Cardiac Surgery and MDT Corporate based in Minneapolis and Hong Kong. Key positions included GM for Cardiac Surgery in Asia Pacific and VP of Global Supply Chain. MBA from University of Michigan and B.S. in Electrical Engineering from General Motors Institute.
Wei Zhang, M.D., Ph.D.
Senior Vice President, Chief Strategy Officer
Formerly faculty of Peking University and China Europe International Business School (CEIBS), and founding director of Health Care Management and Policy Center at CEIBS. Co-founded multiple start-ups across different sectors. Responsible for company strategy management. M.D. from Peking Union Medical College, and Ph.D. in Health Policy from Harvard University.